Who makes Emtriva? A look at Gilead Sciences and the development of this HIV medication
•
3 min read
In July 2003, the U.S. Food and Drug Administration (FDA) approved the once-daily HIV medication **Emtriva**. The biopharmaceutical company Gilead Sciences, Inc. holds the trademark and is responsible for the manufacturing and marketing of this essential antiretroviral drug.
